Maternal Sepsis: Why Is It Still in the Top 3 for Global Incidence of Sepsis? (Session 14 – 4th WSC)
Maternal Sepsis: Why Is It Still in the Top 3 for Global Incidence of Sepsis? (Session 14 – 4th WSC)
Session 14 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:00:00 Intro
00:36 Mercedes Bonet – Introduction
03:48 Alan Tita – An Epidemiology-Based Assessment of the Problem
08:55 Sharing the Story (Video)
15:06 Helen Cheyne – Sepsis Awareness and the Importance of Advocacy – Perspective of a Midwife and Sepsis Survivor
21:46 Maria Fernanda Escobar Vidarte – Early Detection and Management – What Does It Mean for Maternal Sepsis?
26:38 Sabina Abou Malham – Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in the Lebanon and Beyond?
30:19 Edgardo Abalos – Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in Argentina and Beyond?
37:11 Discussion by the Panelists
1:23:39 Benedetta Allegranzi – The Perspective of the World Health Organization
All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518
Session 13 is already available. Sessions 15 and 16 will follow on June 20, 2023. The full release schedule is available at https://www.worldsepsiscongress.org/watch
Thanks for watching and sharing.
The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.
Stop Sepsis – Save Lives
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.